Protalix BioTherapeutics Articles
New briefs on Pfizer interest in Protalix; Novo Nordisk warning letter; Hemispherx' Ampligen; and Idenix' hep C program
6 February 2013
Protalix and Pfizer expand Elelyso agreement
7 December 2012
Pfizer 3rd-qtr profits slump on lower than expected sales; EU says "no" to Gaucher drug
2 November 2012
Protalix gains Israeli approval for Gaucher drug Elelyso
1 October 2012
Protalix submits CRL reply to FDA on Gaucher drug taliglucerase; reports new trial data
2 August 2011
US FDA stalls Protalix Gaucher drug taliglucerase, calling for more data, but not new trials
28 February 2011
Showing 1-12 of 12 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
